Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
1996 1
2000 1
2001 2
2002 2
2004 1
2008 2
2012 1
2014 1
2016 1
2017 1
2018 1
2023 2
2024 1
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Tinea pedis: an updated review.
Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Leung AK, et al. Drugs Context. 2023 Jun 29;12:2023-5-1. doi: 10.7573/dic.2023-5-1. eCollection 2023. Drugs Context. 2023. PMID: 37415917 Free PMC article. Review.
This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis. METHODS: A search was conducted in April 2023 in PubMed Clinical Queries using the key terms 'tinea pedis' OR 'athlete's foot'. ...CO …
This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis. METHODS …
Topical Luliconazole Treatment for Hyperkeratotic Tinea Pedis.
Ohara S, Noguchi H, Matsumoto T, Hayashi D, Kashiwada-Nakamura K, Kubo M, Kano R, Fukushima S. Ohara S, et al. Mycopathologia. 2025 Jul 23;190(5):66. doi: 10.1007/s11046-025-00977-z. Mycopathologia. 2025. PMID: 40696008
Chronic hyperkeratotic tinea pedis is a treatment-resistant infection. We evaluated the efficacy of a 3-month course of topical 1% luliconazole in 21 hyperkeratotic tinea pedis patients. ...These findings suggest that 1% topical lu …
Chronic hyperkeratotic tinea pedis is a treatment-resistant infection. We evaluated the efficacy of a 3-month co …
Topical treatment for moccasin-type tinea pedis.
Greer DL. Greer DL. J Am Acad Dermatol. 1987 Mar;16(3 Pt 1):554-8. doi: 10.1016/s0190-9622(87)70073-5. J Am Acad Dermatol. 1987. PMID: 3546420 Clinical Trial.
Sixty patients were treated for tinea pedis with 2% topical ketoconazole cream either once or twice daily. All diagnoses were confirmed mycologically. ...Of practical interest, however, was the high number of responders among the moccasin-type of tinea
Sixty patients were treated for tinea pedis with 2% topical ketoconazole cream either once or twice daily. All diagnoses
Treatment of tinea pedis with a single pulse of itraconazole.
Bonifaz A, Saúl A. Bonifaz A, et al. Eur J Dermatol. 2002 Mar-Apr;12(2):157-9. Eur J Dermatol. 2002. PMID: 11872413 Clinical Trial.
An open-design, prospective, non-comparative study was conducted to evaluate the efficacy and safety of itraconazole in the treatment of tinea pedis (interdigital-type, hyperkeratotic-type and the combination of both). ...We concluded that the administ …
An open-design, prospective, non-comparative study was conducted to evaluate the efficacy and safety of itraconazole in the treatment
Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
Shi TW, Zhang JA, Zhang XW, Yu HX, Tang YB, Yu JB. Shi TW, et al. Mycoses. 2014 Sep;57(9):560-4. doi: 10.1111/myc.12198. Epub 2014 Apr 3. Mycoses. 2014. PMID: 24697872 Clinical Trial.
Hyperkeratotic-type tinea pedis is chronic and recalcitrant to topical antifungal agents. Some topical antifungal agents are effective; however, long duration of therapy is required, which often reduce the treatment compliance of patients. To se
Hyperkeratotic-type tinea pedis is chronic and recalcitrant to topical antifungal agents. Some topical antifungal agent
The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis.
Vlahovic TC. Vlahovic TC. J Drugs Dermatol. 2016 Feb;15(2 Suppl):s56-9. J Drugs Dermatol. 2016. PMID: 26885800 Review.
In recent years, new topical antifungals have emerged for the treatment and management of tinea pedis, but all have been investigated and approved for the treatment of interdigital tinea pedis. ...Naftifine 2% cream in combination with ur …
In recent years, new topical antifungals have emerged for the treatment and management of tinea pedis, but all have bee …
Usefulness of lanoconazole (Astat) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% urea ointment (Pastaron).
Tanuma H, Tanuma M, Abe M, Kume H. Tanuma H, et al. Mycoses. 2001;44(5):181-90. doi: 10.1046/j.0933-7407.2001.00607.x. Mycoses. 2001. PMID: 11486456 Clinical Trial.
Hyperkeratotic type tinea pedis is a refractory type of superficial dermatomycosis. Treatment for hyperkeratotic type tinea pedis is mainly with oral antimycotics, such as griseofulvin, and healing is generally considered to be dif
Hyperkeratotic type tinea pedis is a refractory type of superficial dermatomycosis. Treatment for hyperkerato
Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
Kikuchi I, Tanuma H, Morimoto K, Kawana S. Kikuchi I, et al. Mycoses. 2008 Nov;51(6):523-31. doi: 10.1111/j.1439-0507.2008.01509.x. Epub 2008 Apr 16. Mycoses. 2008. PMID: 18422915 Clinical Trial.
To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic-type tinea pedis from the pharmacokinetic point of view, 20 patients with hyperkeratotic-type tinea pedis were given TBF 125 …
To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic-type tinea
Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.
Kikuchi I, Tanuma H, Morimoto K, Kawana S. Kikuchi I, et al. Mycoses. 2008 Jan;51(1):7-13. doi: 10.1111/j.1439-0507.2007.01438.x. Mycoses. 2008. PMID: 18076589 Clinical Trial.
To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic type tinea pedis, from the pharmacokinetic point of view, 20 patients with hyperkeratotic type tinea pedis were given TBF 12 …
To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic type tinea
Usefulness of 1% terbinafine HCl (Lamisil) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layer.
Tanuma H, Doi M, Ohta Y, Nishiyama S, Katsuoka K, Kaneko S, Mukai H, Abe M. Tanuma H, et al. Mycoses. 2000;43(11-12):417-32. Mycoses. 2000. PMID: 11204359 Clinical Trial.
Hyperkeratotic-type tinea pedis was classified into three types: true hyperkeratotic-type, partial hyperkeratotic-type, and quasi-hyperkeratotic type. ...These findings indicate that terbinafine HCl (Lamisil) cream is very useful for refr
Hyperkeratotic-type tinea pedis was classified into three types: true hyperkeratotic-type, partial hyperkerat
21 results